| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.787 | 14.396 | 14.159 | 18.660 | 9.771 | 11.665 | 11.982 | 7.666 | 7.779 |
| Total Income - EUR | - | 4.787 | 14.396 | 14.159 | 18.660 | 9.771 | 11.665 | 11.982 | 7.666 | 7.779 |
| Total Expenses - EUR | - | 2.241 | 4.108 | 5.831 | 5.144 | 5.746 | 5.175 | 5.005 | 5.740 | 4.943 |
| Gross Profit/Loss - EUR | - | 2.545 | 10.288 | 8.328 | 13.516 | 4.024 | 6.490 | 6.977 | 1.927 | 2.835 |
| Net Profit/Loss - EUR | - | 2.402 | 9.856 | 7.913 | 12.956 | 3.777 | 6.193 | 6.624 | 1.300 | 2.175 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Patolog Resiga Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 1.828 | 690 | 924 | 334 | 0 | 0 | 504 | 215 |
| Current Assets | - | 4.811 | 8.241 | 8.070 | 14.050 | 5.799 | 6.947 | 6.997 | 2.841 | 2.220 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 758 | 2.316 | 1.376 | 2.584 | 1.079 | 1.476 | 425 | -16 | 0 |
| Cash | - | 4.052 | 5.925 | 6.695 | 11.466 | 4.720 | 5.471 | 6.572 | 2.857 | 2.220 |
| Shareholders Funds | - | 2.446 | 9.900 | 7.965 | 13.006 | 3.827 | 6.223 | 6.673 | 1.349 | 2.224 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.364 | 169 | 795 | 1.994 | 2.333 | 750 | 349 | 1.997 | 211 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Patolog Resiga Srl